To hear about similar clinical trials, please enter your email below

Trial Title: A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers

NCT ID: NCT06305741

Condition: Cancer Patients
Care Givers

Conditions: Official terms:
Anxiety Disorders

Conditions: Keywords:
Anxiety Intervention
Latino caregivers
24-060

Study type: Interventional

Study phase: N/A

Overall status: Recruiting

Study design:

Allocation: N/A

Intervention model: Single Group Assignment

Primary purpose: Supportive Care

Masking: None (Open Label)

Intervention:

Intervention type: Other
Intervention name: Managing Anxiety from Cancer (MAC)
Description: The intervention, MAC, is a seven-session (45-60 minutes per session) psychotherapy intervention delivered via videoconference. and/or telephone by licensed social workers
Arm group label: Latino caregivers and the Latino older adults with cancer (OACs)

Summary: The purpose of this study is to find out if an anxiety treatment program is practical and effective for Latino older adults with cancer (OACs) and their caregivers.

Criteria for eligibility:
Criteria:
Inclusion Criteria: Older Adults with Cancer (OAC) - As per medical record or self-report, is currently age 65 years or older - As per medical record or self-report, currently receiving active cancer treatment OR is within eighteen months of completing active treatment which includes surgery, chemotherapy, radiation, and immunotherapy. - As per self-report, identifies as Latino and/or Hispanic Ethnicity - Per self-report, has a primary informal caregiver (as defined by an unpaid individual who provides the patient with emotional, physical, and/or practical support) age 40 or older who is willing and able to participate in the study - Scores ≥8 on the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS) - Per self-report, fluent in English and/or Spanish** ** Language verification: Prior to enrollment, patients will be asked the following two questions by a Clinical Research Coordinator (CRC) to verify language fluency necessary for participation in the study: 1. How well do you speak English and/or Spanish? (must respond "very well" or "well" when given the choices of Very well, Well, Not well, Not at all, Don't know, or Refused) 2. What is your preferred language for healthcare? (must respond English and/or Spanish) Caregiver - Per OAC report, is primary informal caregiver (as defined by an unpaid individual who provides the patient with emotional, physical, and/or practical support) for the eligible OAC patient - As per self-report, is age 40 years or older - As per self-report, identifies as Latino and/or Hispanic Ethnicity - Per self-report, fluent in English and/or Spanish** ** Language verification: Prior to enrollment, patients will be asked the following two questions by a Clinical Research Coordinator (CRC) to verify language fluency necessary for participation in the study: 1. How well do you speak English and/or Spanish? (must respond "very well" or "well" when given the choices of Very well, Well, Not well, Not at all, Don't know, or Refused) 2. What is your preferred language for healthcare? (must respond English and/or Spanish) Exclusion Criteria: OAC - As per medical record or self-report, currently receiving psychotherapy - As per medical record or self-report, taking psychotropic medications for < 8 weeks prior to MAC Session 1 and/or anticipates changing their medication during the study - As per medical record or self-report, currently being treated for schizophrenia, substance use or dependence, and/or bi-polar disorder - Severely cognitively impaired as demonstrated by Blessed Orientation Memory Concentration score ≥ 9 - Per research staff judgment and/or self-report, too ill or weak to complete study procedures - Per medical record or self-report, receiving hospice care at the time of enrollment - Does not have a caregiver who meets study eligibility criteria and is willing to participate in the study. Caregiver - As per self-report, currently receiving psychotherapy - As per self-report, taking psychotropic medications for < 8 weeks prior to MAC Session 1 and/or anticipates changing their medication during the study - As per self-report, currently being treated for schizophrenia, substance use or dependence, and/or bi-polar disorder - Severely cognitively impaired as demonstrated by Blessed Orientation Memory Concentration score ≥ 11 - Per research staff judgment and/or self-report, too ill or weak to complete study procedures

Gender: All

Minimum age: 40 Years

Maximum age: N/A

Healthy volunteers: Accepts Healthy Volunteers

Locations:

Facility:
Name: Memorial Sloan Kettering at Basking Ridge (All Protocol Activities)

Address:
City: Basking Ridge
Zip: 07920
Country: United States

Status: Recruiting

Contact:
Last name: Kelly McConnell, PhD

Phone: 646-888-0026

Facility:
Name: Memorial Sloan Kettering Monmouth (All Protocol Activities)

Address:
City: Middletown
Zip: 07748
Country: United States

Status: Recruiting

Contact:
Last name: Kelly McConnell, PhD

Phone: 646-888-0026

Facility:
Name: Memorial Sloan Kettering Bergen (All Protocol Activities)

Address:
City: Montvale
Zip: 07645
Country: United States

Status: Recruiting

Contact:
Last name: Kelly McConnell, PhD

Phone: 646-888-0026

Facility:
Name: Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)

Address:
City: Commack
Zip: 11725
Country: United States

Status: Recruiting

Contact:
Last name: Kelly McConnell, PhD

Phone: 646-888-0026

Facility:
Name: Memorial Sloan Kettering Westchester (All Protocol Activities)

Address:
City: Harrison
Zip: 10604
Country: United States

Status: Recruiting

Contact:
Last name: Kelly McConnell, PhD

Phone: 646-888-0026

Facility:
Name: Memorial Sloan Kettering Cancer Center (All protocol activities)

Address:
City: New York
Zip: 10065
Country: United States

Status: Recruiting

Contact:
Last name: Kelly McConnell, PhD

Phone: 646-888-0026

Facility:
Name: Memorial Sloan Kettering Nassau (All Protocol Activities)

Address:
City: Rockville Centre
Zip: 11553
Country: United States

Status: Recruiting

Contact:
Last name: Kelly McConnell, PhD

Phone: 646-888-0026

Start date: March 5, 2024

Completion date: March 2026

Lead sponsor:
Agency: Memorial Sloan Kettering Cancer Center
Agency class: Other

Source: Memorial Sloan Kettering Cancer Center

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT06305741
http://www.mskcc.org/mskcc/html/44.cfm

Login to your account

Did you forget your password?